Cargando…

Human Treated Dentin Matrix Hydrogel as a Drug Delivery Scaffold for Regenerative Endodontics

INTRODUCTION: The objective of the current study was to develop a human treated dentin matrix (hTDM) hydrogel for use as a scaffold to allow the controlled release of an antimicrobial agent for regenerative endodontics. MATERIALS AND METHODS: Human extracted teeth were treated via chemical demineral...

Descripción completa

Detalles Bibliográficos
Autores principales: Sedek, Eman Mohamed, Barakat, Hebatallah Soliman, Lotfy, Walid Ahmed, Moussa, Sybel Mohktar, AbouShelib, Moustafa, El Backly, Rania M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Iranian Center for Endodontic Research 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9868998/
https://www.ncbi.nlm.nih.gov/pubmed/36703697
http://dx.doi.org/10.22037/iej.v17i4.35580
_version_ 1784876671818530816
author Sedek, Eman Mohamed
Barakat, Hebatallah Soliman
Lotfy, Walid Ahmed
Moussa, Sybel Mohktar
AbouShelib, Moustafa
El Backly, Rania M.
author_facet Sedek, Eman Mohamed
Barakat, Hebatallah Soliman
Lotfy, Walid Ahmed
Moussa, Sybel Mohktar
AbouShelib, Moustafa
El Backly, Rania M.
author_sort Sedek, Eman Mohamed
collection PubMed
description INTRODUCTION: The objective of the current study was to develop a human treated dentin matrix (hTDM) hydrogel for use as a scaffold to allow the controlled release of an antimicrobial agent for regenerative endodontics. MATERIALS AND METHODS: Human extracted teeth were treated via chemical demineralization using ethylene diamine tetra-acetic acid solution to produce hTDM powder. Fourier transform infrared spectroscopy (FTIR) was conducted to determine the functional groups of hTDM, scanning electron microscopy (SEM) was used to define the morphology/particle size of hTDM, and energy dispersive X-ray analysis was performed to identify the superficial apatite groups. Prepared hTDM powder was added to the amoxicillin-clavulanate mixture with a mass ratio of 1:1. Then, the combination was dripped into a 5% (w/v) calcium chloride solution. Antibiotic release profiles were evaluated for 14 days via high performance liquid chromatography (HPLC). Hydrogel degradation properties were studied for 14 days using 10 mL of phosphate buffered saline (PBS). Encapsulation efficiency was determined by HPLC, while minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) of amoxicillin-clavulanate were determined against Enterococcus faecalis (E. faecalis). The antibacterial activity of amoxicillin-clavulanate against E. faecalis was investigated for 14 days via agar diffusion test. Statistical analysis was performed with the Shapiro-Wilk test (P=0.05). RESULTS: hTDM showed statistically a significant difference for percentage weight change (P=0.1). The encapsulation efficiencies for hTDM hydrogel with antibiotic and hydrogel with antibiotic was 96.08%±0.02 and 94.62%±0.11, respectively. MIC and MBC values of amoxicillin-clavulanate against E. faecalis were 2.4 µg/mL and 9.6 µg/mL, respectively. The antibacterial activity of antibiotic loaded hTDM hydrogels was significantly greater than loaded hydrogels alone by 31% after 4 days and 100% at 14 days, respectively (P≤0.001). CONCLUSIONS: This in vitro study showed antibiotic-loaded injectable hTDM hydrogel could be an alternative system to transfer antibiotic-based intracanal medicaments for use in regenerative endodontics.
format Online
Article
Text
id pubmed-9868998
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Iranian Center for Endodontic Research
record_format MEDLINE/PubMed
spelling pubmed-98689982023-01-25 Human Treated Dentin Matrix Hydrogel as a Drug Delivery Scaffold for Regenerative Endodontics Sedek, Eman Mohamed Barakat, Hebatallah Soliman Lotfy, Walid Ahmed Moussa, Sybel Mohktar AbouShelib, Moustafa El Backly, Rania M. Iran Endod J Original Article INTRODUCTION: The objective of the current study was to develop a human treated dentin matrix (hTDM) hydrogel for use as a scaffold to allow the controlled release of an antimicrobial agent for regenerative endodontics. MATERIALS AND METHODS: Human extracted teeth were treated via chemical demineralization using ethylene diamine tetra-acetic acid solution to produce hTDM powder. Fourier transform infrared spectroscopy (FTIR) was conducted to determine the functional groups of hTDM, scanning electron microscopy (SEM) was used to define the morphology/particle size of hTDM, and energy dispersive X-ray analysis was performed to identify the superficial apatite groups. Prepared hTDM powder was added to the amoxicillin-clavulanate mixture with a mass ratio of 1:1. Then, the combination was dripped into a 5% (w/v) calcium chloride solution. Antibiotic release profiles were evaluated for 14 days via high performance liquid chromatography (HPLC). Hydrogel degradation properties were studied for 14 days using 10 mL of phosphate buffered saline (PBS). Encapsulation efficiency was determined by HPLC, while minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) of amoxicillin-clavulanate were determined against Enterococcus faecalis (E. faecalis). The antibacterial activity of amoxicillin-clavulanate against E. faecalis was investigated for 14 days via agar diffusion test. Statistical analysis was performed with the Shapiro-Wilk test (P=0.05). RESULTS: hTDM showed statistically a significant difference for percentage weight change (P=0.1). The encapsulation efficiencies for hTDM hydrogel with antibiotic and hydrogel with antibiotic was 96.08%±0.02 and 94.62%±0.11, respectively. MIC and MBC values of amoxicillin-clavulanate against E. faecalis were 2.4 µg/mL and 9.6 µg/mL, respectively. The antibacterial activity of antibiotic loaded hTDM hydrogels was significantly greater than loaded hydrogels alone by 31% after 4 days and 100% at 14 days, respectively (P≤0.001). CONCLUSIONS: This in vitro study showed antibiotic-loaded injectable hTDM hydrogel could be an alternative system to transfer antibiotic-based intracanal medicaments for use in regenerative endodontics. Iranian Center for Endodontic Research 2022 /pmc/articles/PMC9868998/ /pubmed/36703697 http://dx.doi.org/10.22037/iej.v17i4.35580 Text en https://creativecommons.org/licenses/by-nc-sa/4.0/This open-access article has been distributed under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0).https://creativecommons.org/licenses/by-nc-sa/4.0/
spellingShingle Original Article
Sedek, Eman Mohamed
Barakat, Hebatallah Soliman
Lotfy, Walid Ahmed
Moussa, Sybel Mohktar
AbouShelib, Moustafa
El Backly, Rania M.
Human Treated Dentin Matrix Hydrogel as a Drug Delivery Scaffold for Regenerative Endodontics
title Human Treated Dentin Matrix Hydrogel as a Drug Delivery Scaffold for Regenerative Endodontics
title_full Human Treated Dentin Matrix Hydrogel as a Drug Delivery Scaffold for Regenerative Endodontics
title_fullStr Human Treated Dentin Matrix Hydrogel as a Drug Delivery Scaffold for Regenerative Endodontics
title_full_unstemmed Human Treated Dentin Matrix Hydrogel as a Drug Delivery Scaffold for Regenerative Endodontics
title_short Human Treated Dentin Matrix Hydrogel as a Drug Delivery Scaffold for Regenerative Endodontics
title_sort human treated dentin matrix hydrogel as a drug delivery scaffold for regenerative endodontics
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9868998/
https://www.ncbi.nlm.nih.gov/pubmed/36703697
http://dx.doi.org/10.22037/iej.v17i4.35580
work_keys_str_mv AT sedekemanmohamed humantreateddentinmatrixhydrogelasadrugdeliveryscaffoldforregenerativeendodontics
AT barakathebatallahsoliman humantreateddentinmatrixhydrogelasadrugdeliveryscaffoldforregenerativeendodontics
AT lotfywalidahmed humantreateddentinmatrixhydrogelasadrugdeliveryscaffoldforregenerativeendodontics
AT moussasybelmohktar humantreateddentinmatrixhydrogelasadrugdeliveryscaffoldforregenerativeendodontics
AT aboushelibmoustafa humantreateddentinmatrixhydrogelasadrugdeliveryscaffoldforregenerativeendodontics
AT elbacklyraniam humantreateddentinmatrixhydrogelasadrugdeliveryscaffoldforregenerativeendodontics